Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.

[1]  Marie Strickland,et al.  Metabolic Reprogramming in Glioma , 2017, Front. Cell Dev. Biol..

[2]  T. Seyfried,et al.  Ultrastructural characterization of the Mitochondria-associated membranes abnormalities in human astrocytomas: Functional and therapeutics implications , 2017, Ultrastructural pathology.

[3]  F. Guadagni,et al.  Ketogenic Diet and Other Dietary Intervention Strategies in the Treatment of Cancer. , 2017, Current medicinal chemistry.

[4]  F. Khuri,et al.  Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth. , 2017, Cell metabolism.

[5]  Ganesh Rao,et al.  Identification of Histological Correlates of Overall Survival in Lower Grade Gliomas Using a Bag-of-words Paradigm: A Preliminary Analysis Based on Hematoxylin & Eosin Stained Slides from the Lower Grade Glioma Cohort of The Cancer Genome Atlas , 2017, Journal of pathology informatics.

[6]  Dohoon Kim,et al.  Cancer Metabolism: Fueling More than Just Growth , 2016, Molecules and cells.

[7]  N. Syed,et al.  Tumor Metabolism, the Ketogenic Diet and β-Hydroxybutyrate: Novel Approaches to Adjuvant Brain Tumor Therapy , 2016, Front. Mol. Neurosci..

[8]  A. Vazquez,et al.  Cancer metabolism at a glance , 2016, Journal of Cell Science.

[9]  F. Hyder,et al.  A ketogenic diet increases transport and oxidation of ketone bodies in RG2 and 9L gliomas without affecting tumor growth. , 2016, Neuro-oncology.

[10]  John L. Johnson,et al.  Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic diet , 2016, BMC Cancer.

[11]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[12]  U. Kämmerer,et al.  Anti-Tumor Effects of Ketogenic Diets in Mice: A Meta-Analysis , 2016, PloS one.

[13]  J. Mahmoudi,et al.  The efficacy of the ketogenic diet on motor functions in Parkinson’s disease: A rat model , 2016, Iranian journal of neurology.

[14]  D. D'Agostino,et al.  Metabolic effects of exogenous ketone supplementation – an alternative or adjuvant to the ketogenic diet as a cancer therapy? , 2016 .

[15]  U. Bogdahn,et al.  Diabetes, use of antidiabetic drugs, and the risk of glioma. , 2016, Neuro-oncology.

[16]  S. Minucci,et al.  Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia , 2016, British Journal of Cancer.

[17]  K. Polański,et al.  Long-term High Fat Ketogenic Diet Promotes Renal Tumor Growth in a Rat Model of Tuberous Sclerosis , 2016, Scientific Reports.

[18]  C. Ari,et al.  Effects of exogenous ketone supplementation on blood ketone, glucose, triglyceride, and lipoprotein levels in Sprague–Dawley rats , 2016, Nutrition & Metabolism.

[19]  J. Debus,et al.  The influence of hyperglycemia during radiotherapy on survival in patients with primary glioblastoma , 2016, Acta oncologica.

[20]  C. Thompson,et al.  The Emerging Hallmarks of Cancer Metabolism. , 2016, Cell metabolism.

[21]  Musa A. Jundi,et al.  A Supplemented High-Fat Low-Carbohydrate Diet for the Treatment of Glioblastoma , 2015, Clinical Cancer Research.

[22]  Gloria S. Huang,et al.  Designing a broad-spectrum integrative approach for cancer prevention and treatment. , 2015, Seminars in cancer biology.

[23]  Gang Zhao,et al.  NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells. , 2015, Cancer letters.

[24]  S. C. Stoner,et al.  Community pharmacy patient perceptions of a pharmacy‐initiated mobile technology app to improve adherence , 2015, The International journal of pharmacy practice.

[25]  Heng-hua Cui,et al.  Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach , 2015, International journal of molecular sciences.

[26]  A. Scheck,et al.  Abstract 3346: The ketone body β-hydroxybutyrate increases radiosensitivity in glioma cell lines in vitro , 2015 .

[27]  M. Preul,et al.  The Ketogenic Diet Alters the Hypoxic Response and Affects Expression of Proteins Associated with Angiogenesis, Invasive Potential and Vascular Permeability in a Mouse Glioma Model , 2015, PloS one.

[28]  T. Seyfried,et al.  Non-Toxic Metabolic Management of Metastatic Cancer in VM Mice: Novel Combination of Ketogenic Diet, Ketone Supplementation, and Hyperbaric Oxygen Therapy , 2015, PloS one.

[29]  M. Attimonelli,et al.  A comprehensive characterization of mitochondrial DNA mutations in glioblastoma multiforme. , 2015, The international journal of biochemistry & cell biology.

[30]  A. Cicero,et al.  Middle and Long-Term Impact of a Very Low-Carbohydrate Ketogenic Diet on Cardiometabolic Factors: A Multi-Center, Cross-Sectional, Clinical Study , 2015, High Blood Pressure & Cardiovascular Prevention.

[31]  C. Brennan,et al.  Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo , 2015, Science Translational Medicine.

[32]  P. A. Crawford,et al.  Ketone body β-hydroxybutyrate blocks the NLRP3 inflammasome-mediated inflammatory disease , 2015, Nature Medicine.

[33]  Y. Fujibayashi,et al.  Acetate/acetyl-CoA metabolism associated with cancer fatty acid synthesis: overview and application. , 2015, Cancer letters.

[34]  D. Brat,et al.  Molecular Pathways in Gliomagenesis and Their Relevance to Neuropathologic Diagnosis , 2015, Advances in anatomic pathology.

[35]  I. Nakano.  Therapeutic potential of targeting glucose metabolism in glioma stem cells , 2014, Expert opinion on therapeutic targets.

[36]  Yongxian Zhuang,et al.  Mechanisms by Which Low Glucose Enhances the Cytotoxicity of Metformin to Cancer Cells Both In Vitro and In Vivo , 2014, PloS one.

[37]  S. Grant,et al.  Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights. , 2014, Pharmacology & therapeutics.

[38]  H. Duffau,et al.  New concepts in the management of diffuse low-grade glioma: Proposal of a multistage and individualized therapeutic approach. , 2014, Neuro-oncology.

[39]  N. Hay,et al.  The pentose phosphate pathway and cancer. , 2014, Trends in biochemical sciences.

[40]  M. Todaro,et al.  Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment , 2014, Cell Death and Disease.

[41]  K. Vousden,et al.  Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. , 2014, Cell reports.

[42]  T. Seyfried,et al.  Ketone supplementation decreases tumor cell viability and prolongs survival of mice with metastatic cancer , 2014, International journal of cancer.

[43]  R. Kalff,et al.  Overexpression of fatty acid synthase in human gliomas correlates with the WHO tumor grade and inhibition with Orlistat reduces cell viability and triggers apoptosis , 2014, Journal of Neuro-Oncology.

[44]  M. Weller,et al.  ERGO: A pilot study of ketogenic diet in recurrent glioblastoma , 2014, International journal of oncology.

[45]  E. Verdin,et al.  Ketone bodies as signaling metabolites , 2014, Trends in Endocrinology & Metabolism.

[46]  James J. Evans,et al.  Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme , 2014, Journal of Neuro-Oncology.

[47]  M. C. Archer,et al.  Fatty acid synthase plays a role in cancer metabolism beyond providing fatty acids for phospholipid synthesis or sustaining elevations in glycolytic activity. , 2014, Experimental cell research.

[48]  S. Lonial,et al.  PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma. , 2013, Blood.

[49]  Leif Benner,et al.  Ketogenic Diet Improves Motor Performance but Not Cognition in Two Mouse Models of Alzheimer’s Pathology , 2013, PloS one.

[50]  P. Dráber,et al.  Mitochondrial dysfunction in gliomas. , 2013, Seminars in pediatric neurology.

[51]  Andrew E. Sloan,et al.  Brain Tumor Initiating Cells Adapt to Restricted Nutrition through Preferential Glucose Uptake , 2013, Nature Neuroscience.

[52]  K. Anderson,et al.  Preclinical data and early clinical experience supporting the use of histone deacetylase inhibitors in multiple myeloma. , 2013, Leukemia research.

[53]  A. Paoli,et al.  Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets , 2013, European Journal of Clinical Nutrition.

[54]  Brian J. Smith,et al.  Ketogenic Diets Enhance Oxidative Stress and Radio-Chemo-Therapy Responses in Lung Cancer Xenografts , 2013, Clinical Cancer Research.

[55]  T. Seyfried,et al.  The Ketogenic Diet and Hyperbaric Oxygen Therapy Prolong Survival in Mice with Systemic Metastatic Cancer , 2013, PloS one.

[56]  M. Mattson,et al.  A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease , 2013, Neurobiology of Aging.

[57]  H. Brunengraber,et al.  Therapeutic ketosis with ketone ester delays central nervous system oxygen toxicity seizures in rats. , 2013, American journal of physiology. Regulatory, integrative and comparative physiology.

[58]  J. Olson,et al.  Prediagnostic body weight and survival in high grade glioma , 2013, Journal of Neuro-Oncology.

[59]  L. Szablewski.  Expression of glucose transporters in cancers. , 2013, Biochimica et biophysica acta.

[60]  M. Tan,et al.  Targeting cellular metabolism to improve cancer therapeutics , 2013, Cell Death and Disease.

[61]  D. Turnbull,et al.  Linking the Metabolic State and Mitochondrial DNA in Chronic Disease, Health, and Aging , 2013, Diabetes.

[62]  I. Bosaeus,et al.  Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients , 2013, Supportive Care in Cancer.

[63]  Eric Verdin,et al.  Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor , 2013, Science.

[64]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[65]  F. Sotgia,et al.  Ketone body utilization drives tumor growth and metastasis , 2012, Cell cycle.

[66]  F. Sotgia,et al.  Ketone bodies and two-compartment tumor metabolism: Stromal ketone production fuels mitochondrial biogenesis in epithelial cancer cells , 2012, Cell cycle.

[67]  G. Egger,et al.  Epigenomics of cancer – emerging new concepts , 2012, Biochimie.

[68]  A. Negassa,et al.  Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients. , 2012, Nutrition.

[69]  K. Nakao,et al.  Branched‐chain amino acid deficiency stabilizes insulin‐induced vascular endothelial growth factor mRNA in hepatocellular carcinoma cells , 2012, Journal of cellular biochemistry.

[70]  P. Stafford,et al.  The ketogenic diet for the treatment of glioma: Insights from genetic profiling , 2012, Epilepsy Research.

[71]  A. Tsirigos,et al.  Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone production , 2012, Cell cycle.

[72]  U. Baxa,et al.  Mitochondrial biogenesis and increased uncoupling protein 1 in brown adipose tissue of mice fed a ketone ester diet , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[73]  P. Stafford,et al.  The Ketogenic Diet Is an Effective Adjuvant to Radiation Therapy for the Treatment of Malignant Glioma , 2012, PloS one.

[74]  C. Ari,et al.  Development, testing and therapeutic applications of ketone esters (KE) for CNS oxygen toxicity (CNS‐OT); i.e., hyperbaric oxygen (HBO2)‐induced seizures , 2012 .

[75]  E. Kossoff,et al.  Ketogenic diets. , 2012, Journal of human nutrition.

[76]  Vito Pistoia,et al.  Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy , 2012, Science Translational Medicine.

[77]  Jong M. Rho,et al.  The Ketogenic Diet as a Treatment Paradigm for Diverse Neurological Disorders , 2012, Front. Pharmacol..

[78]  P. Stone,et al.  Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. , 2011, Critical reviews in oncology/hematology.

[79]  A. Belfiore,et al.  Insulin receptor and cancer. , 2011, Endocrine-related cancer.

[80]  Mélanie Schmidt,et al.  Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial , 2011, Nutrition & metabolism.

[81]  E. Hattingen,et al.  Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy , 2011, BMC Cancer.

[82]  E. Riboli,et al.  Concentrations of IGF-I and IGFBP-3 and Brain Tumor Risk in the European Prospective Investigation into Cancer and Nutrition , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[83]  Adele H. Hite,et al.  Low-carbohydrate diet review: shifting the paradigm. , 2011, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[84]  H. Eloqayli,et al.  [2,4-13C]β-hydroxybutyrate Metabolism in Astrocytes and C6 Glioblastoma Cells , 2011, Neurochemical Research.

[85]  A. Tsirigos,et al.  Ketones and lactate increase cancer cell “stemness,” driving recurrence, metastasis and poor clinical outcome in breast cancer , 2011, Cell cycle.

[86]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[87]  M. Grootveld,et al.  The importance of mitochondria in the tumourigenic phenotype: gliomas as the paradigm (review). , 2011, International journal of molecular medicine.

[88]  T. Seyfried,et al.  Glutamine targeting inhibits systemic metastasis in the VM‐M3 murine tumor model , 2010, International journal of cancer.

[89]  P. Stafford,et al.  The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma , 2010, Nutrition & metabolism.

[90]  A. Tsirigos,et al.  Ketones and lactate “fuel” tumor growth and metastasis , 2010, Cell cycle.

[91]  R. Hamanaka,et al.  Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. , 2010, Trends in biochemical sciences.

[92]  Takashi Watanabe.  Investigational histone deacetylase inhibitors for non-Hodgkin lymphomas , 2010, Expert opinion on investigational drugs.

[93]  Angélica Figueroa,et al.  Potential Role of Sugar Transporters in Cancer and Their Relationship with Anticancer Therapy , 2010, International journal of endocrinology.

[94]  M. McGirt,et al.  Persistent outpatient hyperglycemia is independently associated with survival, recurrence and malignant degeneration following surgery for hemispheric low grade gliomas , 2010, Neurological research.

[95]  P. Stafford,et al.  Abstract 638: Mechanistic studies of the ketogenic diet as an adjuvant therapy for malignant gliomas , 2010 .

[96]  T. Seyfried,et al.  Cancer as a metabolic disease , 2010, Nutrition & metabolism.

[97]  Shuwei Liu,et al.  Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease , 2009, Brain Research.

[98]  L. Costantini,et al.  Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial , 2009, Nutrition & metabolism.

[99]  R. Feinman,et al.  Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2 , 2009, Cancer Cell International.

[100]  R. Mirimanoff,et al.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.

[101]  W. Kraemer,et al.  Carbohydrate Restriction has a More Favorable Impact on the Metabolic Syndrome than a Low Fat Diet , 2009, Lipids.

[102]  Jong M. Rho,et al.  The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies , 2009, Brain Research Reviews.

[103]  Jing Yi,et al.  Cancer cell killing via ROS: To increase or decrease, that is the question , 2008, Cancer biology & therapy.

[104]  T. Seyfried,et al.  Drug/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted ketogenic diet , 2008, Nutrition & metabolism.

[105]  M. McGirt,et al.  PERSISTENT OUTPATIENT HYPERGLYCEMIA IS INDEPENDENTLY ASSOCIATED WITH DECREASED SURVIVAL AFTER PRIMARY RESECTION OF MALIGNANT BRAIN ASTROCYTOMAS , 2008, Neurosurgery.

[106]  Robert J. Gillies,et al.  Causes and Consequences of Increased Glucose Metabolism of Cancers , 2008, Journal of Nuclear Medicine.

[107]  D. McMillan,et al.  An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer , 2008, Proceedings of the Nutrition Society.

[108]  R. Wittig,et al.  Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides , 2008, BMC Cancer.

[109]  G. Arismendi-Morillo,et al.  Biological : Full-length Ultrastructural mitochondrial pathology in human astrocytic tumors : potentials implications pro-therapeutics strategies , 2008 .

[110]  Jeffrey A. Johnson,et al.  Prospective Study of Hyperglycemia and Cancer Risk , 2007, Diabetes Care.

[111]  F. Meyskens,et al.  UC Irvine UC Irvine Previously Published Works Title Reactive oxygen species : a breath of life or death ? , 2007 .

[112]  E. Kossoff,et al.  Long-term use of the ketogenic diet in the treatment of epilepsy. , 2006, Developmental medicine and child neurology.

[113]  R. Gyurko,et al.  Chronic Hyperglycemia Predisposes to Exaggerated Inflammatory Response and Leukocyte Dysfunction in Akita Mice1 , 2006, The Journal of Immunology.

[114]  M. Beal,et al.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.

[115]  Michael A. Rogawski,et al.  Neuroprotective and disease-modifying effects of the ketogenic diet , 2006, Behavioural Pharmacology.

[116]  P. Schumacker,et al.  Reactive oxygen species in cancer cells: live by the sword, die by the sword. , 2006, Cancer cell.

[117]  S. Davis,et al.  Effects of a carbohydrate-restricted diet on emerging plasma markers for cardiovascular disease , 2006, Nutrition & metabolism.

[118]  D. MacGrogan,et al.  A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis , 2006, BMC Neuroscience.

[119]  R. Wood,et al.  Carbohydrate restriction alters lipoprotein metabolism by modifying VLDL, LDL, and HDL subfraction distribution and size in overweight men. , 2006, The Journal of nutrition.

[120]  J. Horowitz,et al.  Effects of dietary carbohydrate restriction with high protein intake on protein metabolism and the somatotropic axis. , 2005, The Journal of clinical endocrinology and metabolism.

[121]  C. Homko,et al.  Effect of a Low-Carbohydrate Diet on Appetite, Blood Glucose Levels, and Insulin Resistance in Obese Patients with Type 2 Diabetes , 2005, Annals of Internal Medicine.

[122]  P. Iyengar,et al.  The Hyperglycemia-induced Inflammatory Response in Adipocytes , 2005, Journal of Biological Chemistry.

[123]  V. Kavsan,et al.  Reduction of the transcription level of the mitochondrial genome in human glioblastoma. , 2005, Cancer letters.

[124]  J. V. Nielsen,et al.  A Low Carbohydrate Diet in Type 1 Diabetes , 2005, Upsala journal of medical sciences.

[125]  M. Sharman,et al.  Comparison of energy-restricted very low-carbohydrate and low-fat diets on weight loss and body composition in overweight men and women , 2004, Nutrition & metabolism.

[126]  J. Volek,et al.  Cardiovascular and hormonal aspects of very-low-carbohydrate ketogenic diets. , 2004, Obesity research.

[127]  J. Modica-Napolitano,et al.  Mitochondrial dysfunction in cancer. , 2004, Mitochondrion.

[128]  M. Yashiro,et al.  Growth-inhibitory effects of the ketone body, monoacetoacetin, on human gastric cancer cells with succinyl-CoA: 3-oxoacid CoA-transferase (SCOT) deficiency. , 2004, Anticancer research.

[129]  W. Kraemer,et al.  Comparison of a Very Low-Carbohydrate and Low-Fat Diet on Fasting Lipids, LDL Subclasses, Insulin Resistance, and Postprandial Lipemic Responses in Overweight Women , 2004, Journal of the American College of Nutrition.

[130]  R. Veech.  The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.

[131]  Jinsong Liu,et al.  Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity , 2004, Cancer Chemotherapy and Pharmacology.

[132]  D. Boyd,et al.  Insulin and Cancer , 2003, Integrative cancer therapies.

[133]  T. Seyfried,et al.  Role of glucose and ketone bodies in the metabolic control of experimental brain cancer , 2003, British Journal of Cancer.

[134]  E. Vining,et al.  Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. , 2003, JAMA.

[135]  J. Slingerland,et al.  Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression , 2003, Cell cycle.

[136]  R. Marfella,et al.  Stress hyperglycemia, inflammation, and cardiovascular events. , 2003, Diabetes care.

[137]  R. Hesslink,et al.  Effects of an 8-week weight-loss program on cardiovascular disease risk factors and regional body composition , 2002, European Journal of Clinical Nutrition.

[138]  K. Lillehei,et al.  A threshold concept for cancer therapy. , 2000, Medical hypotheses.

[139]  I. Sayek,et al.  Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients. , 2000, Clinical biochemistry.

[140]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[141]  A. Adamis,et al.  Insulin-induced vascular endothelial growth factor expression in retina. , 1999, Investigative ophthalmology & visual science.

[142]  B. Dutrillaux,et al.  Gliomas are driven by glycolysis: putative roles of hexokinase, oxidative phosphorylation and mitochondrial ultrastructure. , 1997, Anticancer research.

[143]  L. Hays,et al.  Mitochondrial DNA copy number changes in human gliomas. , 1996, Cancer letters.

[144]  K. Frayn.  Metabolic Regulation: A Human Perspective , 1996 .

[145]  L. Nebeling,et al.  Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports. , 1995, Journal of the American College of Nutrition.

[146]  D. Fell,et al.  Control of glucose utilization in working perfused rat heart. , 1994, The Journal of biological chemistry.

[147]  T. Iguchi,et al.  Correlation between mammary tumor and blood glucose, serum insulin, and free fatty acids in mice. , 1989, Cancer research.

[148]  D. Rosenstreich,et al.  Mechanism of action of a human interleukin 1 inhibitor. , 1987, Cellular immunology.

[149]  Robert L. DeLaPaz,et al.  Glucose metabolism in human gliomas: Correspondence ofin situ andin vitro metabolic rates and altered energy metabolism , 1986, Metabolic Brain Disease.

[150]  P. Turner,et al.  The interaction between i.v. theophylline and chronic oral dosing with slow release nifedipine in volunteers. , 1986, British journal of clinical pharmacology.

[151]  A. Rofe,et al.  The inhibition of malignant cell growth by ketone bodies. , 1979, The Australian journal of experimental biology and medical science.

[152]  R. B. Ramsey,et al.  3‐Oxo acid coenzyme A transferase activity in brain and tumors of the nervous system 1 , 1978, Journal of neurochemistry.

[153]  J. Dawes.  The Postero-superior Quadrant , 1974, The Journal of Laryngology & Otology.

[154]  B. Urbaschek,et al.  [Blood coagulation and serum lipids in pregnant rats following endotoxin injection--studies of the Sanarelli-Shwartzmann phenomenon]. , 1971, Thrombosis et diathesis haemorrhagica.

[155]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[156]  J. Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013. , 2016, Neuro-oncology.

[157]  M. Berger,et al.  Survival and low-grade glioma: the emergence of genetic information. , 2015, Neurosurgical focus.

[158]  Yu-guang Liu,et al.  Aging-related gene signature regulated by Nlrp3 predicts glioma progression. , 2015, American journal of cancer research.

[159]  Kenneth M. Johnson,et al.  The role of inflammation in brain cancer. , 2014, Advances in experimental medicine and biology.

[160]  R. Deberardinis,et al.  Analysis of hypoxia-induced metabolic reprogramming. , 2014, Methods in enzymology.

[161]  L. Chambless,et al.  Type 2 diabetes mellitus and obesity are independent risk factors for poor outcome in patients with high-grade glioma , 2011, Journal of Neuro-Oncology.

[162]  E. Beierle,et al.  Ketone bodies inhibit the viability of human neuroblastoma cells. , 2009, Journal of pediatric surgery.

[163]  S. Pizzo,et al.  Carbohydrate restriction, prostate cancer growth, and the insulin‐like growth factor axis , 2008, The Prostate.

[164]  W. Kraemer,et al.  Comparison of Low Fat and Low Carbohydrate Diets on Circulating Fatty Acid Composition and Markers of Inflammation , 2007, Lipids.

[165]  U. Ungerstedt,et al.  Baseline Levels of Glucose Metabolites, Glutamate and Glycerol in Malignant Glioma Assessed by Stereotactic Microdialysis , 2004, Journal of Neuro-Oncology.

[166]  B. Halliwell,et al.  Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. , 1996, The Biochemical journal.

[167]  J. Tildon,et al.  Utilization of ketone bodies and glucose by established neural cell lines , 1982, Journal of neuroscience research.

[168]  G. D. Potter.  Sclerosis of the base of the skull as a manifestation of nasopharyngeal carcinoma. , 1970, Radiology.